RegulatoryOfficial

MHRA updates London AI regulatory sandbox call with next-stage application details

🇬🇧 MHRA · Wed 18 Nov 2026

The UK regulator has refreshed its invitation to AI-enabled device makers and NHS providers, adding information on what follows the screening of expressions of interest.

The Medicines and Healthcare products Regulatory Agency (MHRA) has updated its call for expressions of interest in the London Region I MHRA Regulatory Sandbox. The guidance page was first published on 30 July 2026 and revised on 18 November 2026.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: MHRA ↗

Article written by VigiEye from the official source (MHRA). AI-assisted; check the source before acting.